Catalina Capital Group LLC Purchases New Holdings in The Allstate Co. (NYSE:ALL)

Catalina Capital Group LLC purchased a new stake in The Allstate Co. (NYSE:ALL) during the third quarter, according to its most recent disclosure with the SEC. The firm purchased 1,334 shares of the insurance provider’s stock, valued at approximately $253,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ALL. Norden Group LLC purchased a new position in Allstate in the 1st quarter valued at about $641,000. BI Asset Management Fondsmaeglerselskab A S lifted its stake in Allstate by 26.1% in the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 4,697 shares of the insurance provider’s stock worth $813,000 after purchasing an additional 973 shares in the last quarter. GSA Capital Partners LLP purchased a new position in Allstate in the 1st quarter worth approximately $566,000. Csenge Advisory Group purchased a new position in Allstate in the 1st quarter worth approximately $213,000. Finally, Geneos Wealth Management Inc. lifted its stake in Allstate by 266.1% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,406 shares of the insurance provider’s stock worth $243,000 after purchasing an additional 1,022 shares in the last quarter. 76.47% of the stock is owned by hedge funds and other institutional investors.

Allstate Stock Up 2.0 %

Allstate stock opened at $188.69 on Thursday. The firm has a 50 day moving average price of $188.89 and a 200 day moving average price of $175.59. The company has a market capitalization of $49.97 billion, a PE ratio of 12.22, a price-to-earnings-growth ratio of 1.73 and a beta of 0.48. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The Allstate Co. has a fifty-two week low of $127.93 and a fifty-two week high of $198.79.

Allstate (NYSE:ALL) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping the consensus estimate of $2.20 by $1.71. The business had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The company’s quarterly revenue was up 14.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.81 earnings per share. Research analysts expect that The Allstate Co. will post 15.23 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. TD Cowen raised their target price on shares of Allstate from $193.00 to $224.00 and gave the stock a “buy” rating in a research note on Tuesday, September 3rd. Keefe, Bruyette & Woods raised their target price on shares of Allstate from $222.00 to $225.00 and gave the stock an “outperform” rating in a research note on Wednesday. Roth Mkm reaffirmed a “buy” rating and set a $200.00 price target on shares of Allstate in a research report on Wednesday, August 14th. Barclays lifted their price target on shares of Allstate from $175.00 to $187.00 and gave the company an “underweight” rating in a research report on Thursday, October 31st. Finally, Evercore ISI lifted their price target on shares of Allstate from $191.00 to $195.00 and gave the company an “in-line” rating in a research report on Wednesday, October 9th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Allstate presently has a consensus rating of “Moderate Buy” and a consensus target price of $209.50.

Insiders Place Their Bets

In other Allstate news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now owns 27,364 shares in the company, valued at $5,236,922.32. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, EVP Elizabeth Brady sold 49,481 shares of the business’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the completion of the transaction, the executive vice president now owns 19,163 shares in the company, valued at approximately $3,431,901.67. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the transaction, the insider now owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 192,530 shares of company stock worth $34,967,665 over the last 90 days. Corporate insiders own 1.80% of the company’s stock.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.